- Home
- LCTX vs HURC Comparison
LCTX vs HURC Comparison
Compare LCTX & HURC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- HURC
- Stock Information
- Founded
- LCTX 1990
- HURC 1968
- Country
- LCTX United States
- HURC United States
- Employees
- LCTX N/A
- HURC N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- HURC Industrial Machinery/Components
- Sector
- LCTX Health Care
- HURC Industrials
- Exchange
- LCTX Nasdaq
- HURC Nasdaq
- Market Cap
- LCTX 107.3M
- HURC 123.9M
- IPO Year
- LCTX N/A
- HURC N/A
- Fundamental
- Price
- LCTX $1.00
- HURC $19.23
- Analyst Decision
- LCTX Strong Buy
- HURC
- Analyst Count
- LCTX 5
- HURC 0
- Target Price
- LCTX $4.20
- HURC N/A
- AVG Volume (30 Days)
- LCTX 1.6M
- HURC 33.6K
- Earning Date
- LCTX 08-12-2025
- HURC 09-05-2025
- Dividend Yield
- LCTX N/A
- HURC N/A
- EPS Growth
- LCTX N/A
- HURC N/A
- EPS
- LCTX N/A
- HURC N/A
- Revenue
- LCTX $9,557,000.00
- HURC $183,634,000.00
- Revenue This Year
- LCTX N/A
- HURC N/A
- Revenue Next Year
- LCTX $244.95
- HURC N/A
- P/E Ratio
- LCTX N/A
- HURC N/A
- Revenue Growth
- LCTX 19.42
- HURC N/A
- 52 Week Low
- LCTX $0.37
- HURC $13.19
- 52 Week High
- LCTX $1.21
- HURC $23.76
- Technical
- Relative Strength Index (RSI)
- LCTX 50.84
- HURC 53.55
- Support Level
- LCTX $1.00
- HURC $18.47
- Resistance Level
- LCTX $1.09
- HURC $19.56
- Average True Range (ATR)
- LCTX 0.08
- HURC 0.87
- MACD
- LCTX -0.02
- HURC -0.17
- Stochastic Oscillator
- LCTX 24.25
- HURC 52.78
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About HURC Hurco Companies Inc.
Hurco Companies Inc is a United States-based industrial technology company. It designs, manufactures, and sells computerized machine tools, consisting mainly of vertical machining centers and turning centers, to companies in the metalworking industry through sales, service, and distribution networks. The company concentrated on designing user-friendly computer control systems that both skilled and unskilled machine tool operators can operate. It generates maximum revenue from the Computerized Machine Tools product. Geographically, It derives a majority of its revenue from the United States of America. Its product categories include 5-Axis VMC; 3-Axis VMC; Horizontal MC and Turning Centers.